Provider: NIHR Journals Library Content:text/plain; charset="UTF-8" TY - GEN LB - 1. AU - National Collaborating Centre for Chronic Conditions TI - Osteoarthritis: national clinical guideline for care and management in adults CY - London PB - Royal College of Physicians PY - 2008 ER - TY - ELEC LB - 2. AU - Agency for Healthcare Research and Quality TI - Treatment of primary and secondary osteoarthritis of the knee UR - www.ahrq.gov/downloads/pub/evidence/pdf/oaknee/oaknee.pdf M1 - 15 September 2008 ER - TY - CHAP LB - 3. AU - Mankin, HJ TI - Clinical features of osteoarthritis A2 - Kelley, WN A2 - Harris, ED A2 - Ruddy, S A2 - Sledge, CB T2 - Textbook of rheumatology CY - Philadelphia PB - W.B. Saunders Company PY - 1981 ER - TY - JOUR LB - 4. AU - Altman, R AU - Asch, E AU - Bloch, D AU - Bole, G AU - Borenstein, D AU - Brandt, K TI - Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association J2 - Arthritis Rheum PY - 1986 VL - 29 SP - 1039 EP - 1049 ER - TY - JOUR LB - 5. AU - Nuki, G TI - Osteoarthritis: a problem of joint failure J2 - Z Rheumatol PY - 1999 VL - 58 SP - 142 EP - 147 ER - TY - JOUR LB - 6. AU - Doherty, M TI - Risk factors for progression of knee osteoarthritis J2 - Lancet PY - 2001 VL - 358 SP - 775 EP - 776 ER - TY - JOUR LB - 7. AU - Arden, N AU - Nevitt, MC TI - Osteoarthritis: epidemiology J2 - Best Pract Res Clin Rheumatol PY - 2006 VL - 20 SP - 3 EP - 25 ER - TY - JOUR LB - 8. AU - Grotle, M AU - Hagen, KB AU - Natvig, B AU - Dahl, FA AU - Kvien, TK TI - Prevalence and burden of osteoarthritis: results from a population survey in Norway J2 - J Rheumatol PY - 2008 VL - 35 SP - 677 EP - 684 ER - TY - JOUR LB - 9. AU - Sowers, M TI - Epidemiology of risk factors for osteoarthritis: systemic factors J2 - Curr Opin Rheumatol PY - 2001 VL - 13 SP - 447 EP - 451 ER - TY - JOUR LB - 10. AU - Dillon, CF AU - Rasch, EK AU - Gu, Q AU - Hirsch, R TI - Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991–94 J2 - J Rheumatol PY - 2006 VL - 33 SP - 2271 EP - 2279 ER - TY - JOUR LB - 11. AU - Yong, PF AU - Milner, PC AU - Payne, JN AU - Lewis, PA AU - Jennison, C TI - Inequalities in access to knee joint replacements for people in need J2 - Ann Rheum Dis PY - 2004 VL - 63 SP - 1483 EP - 1489 ER - TY - JOUR LB - 12. AU - Garstang, SV AU - Stitik, TP TI - Osteoarthritis: epidemiology, risk factors, and pathophysiology J2 - Am J Phys Med Rehabil PY - 2006 VL - 85 SP - S2 EP - S12 ER - TY - JOUR LB - 13. AU - D’Ambrosia, RD TI - Epidemiology of osteoarthritis J2 - Orthopedics PY - 2005 VL - 28 SP - s201 EP - s205 ER - TY - JOUR LB - 14. AU - Fautrel, B AU - Hilliquin, P AU - Rozenberg, S AU - Allaert, FA AU - Coste, P AU - Leclerc, A TI - Impact of osteoarthritis: results of a nationwide survey of 10,000 patients consulting for OA J2 - Joint Bone Spine PY - 2005 VL - 72 SP - 235 EP - 240 ER - TY - JOUR LB - 15. AU - Corti, MC AU - Rigon, C TI - Epidemiology of osteoarthritis: prevalence, risk factors and functional impact J2 - Aging Clin Experiment Res PY - 2003 VL - 15 SP - 359 EP - 363 ER - TY - JOUR LB - 16. AU - Bedson, J AU - Mottram, S AU - Thomas, E AU - Peat, G TI - Knee pain and osteoarthritis in the general population: what influences patients to consult? J2 - Fam Pract PY - 2007 VL - 24 SP - 443 EP - 453 ER - TY - JOUR LB - 17. AU - White, A TI - Osteoarthritis of the knee – an introduction J2 - Acupunct Med PY - 2006 VL - 24 SP - S1 EP - S6 ER - TY - JOUR LB - 18. AU - Williams, FMK AU - Spector, TD TI - Osteoarthritis J2 - Medicine PY - 2006 VL - 34 SP - 364 EP - 368 ER - TY - JOUR LB - 19. AU - Brooks, PM TI - Impact of osteoarthritis on individuals and society: How much disability? Social consequences and health economic implications J2 - Curr Opin Rheumatol PY - 2002 VL - 14 SP - 573 EP - 577 ER - TY - JOUR LB - 20. AU - Dieppe, PA AU - Cushnaghan, J AU - Shepstone, L TI - The Bristol ‘OA500’ study: progression of osteoarthritis (OA) over 3 years and the relationship between clinical and radiographic changes at the knee joint J2 - Osteoarthritis Cartilage PY - 1997 VL - 5 SP - 87 EP - 97 ER - TY - JOUR LB - 21. AU - Buckwalter, JA TI - The impact of osteoarthritis: implications for research J2 - Clin Orthop Relat Res PY - 2004 VL - 427 IS - Suppl. SP - S6 EP - S15 ER - TY - JOUR LB - 22. AU - Johnson, SR AU - Archibald, A AU - Davis, AM AU - Badley, E AU - Wright, JG AU - Hawker, GA TI - Is self-reported improvement in osteoarthritis pain and disability reflected in objective measures? J2 - J Rheumatol PY - 2007 VL - 34 SP - 159 EP - 164 ER - TY - JOUR LB - 23. AU - Bookwala, J AU - Harralson, TL AU - Parmelee, PA TI - Effects of pain on functioning and well-being in older adults with osteoarthritis of the knee J2 - Psychol Aging PY - 2003 VL - 18 SP - 844 EP - 850 ER - TY - JOUR LB - 24. AU - Hawker, GA AU - Stewart, L AU - French, MR AU - Cibere, J AU - Jordan, JM AU - March, L TI - Understanding the pain experience in hip and knee osteoarthritis – an OARSI/OMERACT initiative J2 - Osteoarthritis Cartilage PY - 2008 VL - 16 SP - 415 EP - 422 ER - TY - JOUR LB - 25. AU - Viinamaki, H TI - Sleep disturbance is associated with mental disorder in patients with hip or knee osteoarthritis J2 - Eur J Psychiatry PY - 2002 VL - 16 SP - 9 EP - 13 ER - TY - JOUR LB - 26. AU - Rosemann, T AU - Joos, S AU - Szecsenyi, J AU - Laux, G AU - Wensing, M TI - Health service utilization patterns of primary care patients with osteoarthritis J2 - BMC Health Serv Res PY - 2007 VL - 7 SP - 169 ER - TY - JOUR LB - 27. AU - Jinks, C AU - Ong, BN AU - Richardson, J TI - A mixed methods study to investigate needs assessment for knee pain and disability: population and individual perspectives J2 - BMC Musculoskeletal Disord PY - 2007 VL - 8 SP - 59 ER - TY - RPRT LB - 28. AU - National Institute of Health and Clinical Excellence TI - Osteoarthritis: costing report. Implementing NICE guidelines CY - London PB - NICE PY - 2008 ER - TY - GEN LB - 29. AU - National Institute of Health and Clinical Excellence TI - Osteoarthritis: the care and management of osteoarthritis in adults CY - London PB - NICE PY - 2008 ER - TY - JOUR LB - 30. AU - Chevalier, X AU - Marre, JP AU - de Butler, J AU - Hercek, A TI - Questionnaire survey of management and prescription of general practitioners in knee osteoarthritis: a comparison with 2000 EULAR recommendations J2 - Clin Experiment Rheumatol PY - 2004 VL - 22 SP - 205 EP - 212 ER - TY - RPRT LB - 31. AU - The National Joint Registry TI - National Joint Registry for England and Wales 4th Annual Report CY - Hemel Hempstead PB - The National Joint Registry PY - 2007 ER - TY - JOUR LB - 32. AU - Lord, J AU - Victor, C AU - Littlejohns, P AU - Ross, FM AU - Axford, JS TI - Economic evaluation of a primary care-based education programme for patients with osteoarthritis of the knee J2 - Health Technol Assess PY - 1999 VL - 3 IS - 23 ER - TY - JOUR LB - 33. AU - Victor, CR AU - Triggs, E AU - Ross, F AU - Lord, J AU - Axford, JS TI - Lack of benefit of a primary care-based nurse-led education programme for people with osteoarthritis of the knee J2 - Clin Rheumatol PY - 2005 VL - 24 SP - 358 EP - 364 ER - TY - JOUR LB - 34. AU - Lequesne, M TI - Indices of severity and disease activity for osteoarthritis J2 - Semin Arthritis Rheum PY - 1991 VL - 20 IS - Suppl. 2 SP - 48 EP - 54 ER - TY - JOUR LB - 35. AU - Bellamy, N AU - Buchanan, WW AU - Goldsmith, CH AU - Campbell, J AU - Stitt, LW TI - Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee J2 - J Rheumatol PY - 1988 VL - 15 SP - 1833 EP - 1840 ER - TY - BOOK LB - 36. AU - Bellamy, N TI - Osteoarthritis – an evaluative index for clinical trials CY - Hamilton, Ontario PB - McMaster University PY - 1982 ER - TY - JOUR LB - 37. AU - Bellamy, N AU - Kirwan, J AU - Boers, M AU - Brooks, P AU - Strand, V AU - Tugwell, P TI - Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III J2 - J Rheumatol PY - 1997 VL - 24 SP - 799 EP - 802 ER - TY - JOUR LB - 38. AU - Stratford, PW AU - Kennedy, DM TI - Does parallel item content on WOMAC’s pain and function subscales limit its ability to detect change in functional status? J2 - BMC Musculoskelet Disord PY - 2004 VL - 5 SP - 17 ER - TY - JOUR LB - 39. AU - Tubach, F AU - Wells, GA AU - Ravaud, P AU - Dougados, M TI - Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues J2 - J Rheumatol PY - 2005 VL - 32 SP - 2025 EP - 2029 ER - TY - JOUR LB - 40. AU - Gossec, L AU - Hawker, G AU - Davis, AM AU - Maillefert, JF AU - Lohmander, LS AU - Altman, R TI - OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis J2 - J Rheumatol PY - 2007 VL - 34 SP - 1432 EP - 1435 ER - TY - JOUR LB - 41. AU - Bruyere, O AU - Richy, F AU - Reginster, JY TI - Three year joint space narrowing predicts long term incidence of knee surgery in patients with osteoarthritis: an eight year prospective follow up study J2 - Ann Rheum Dis PY - 2005 VL - 64 SP - 1727 EP - 1730 ER - TY - JOUR LB - 42. AU - Dacre, JE AU - Scott, DL AU - Da Silva, JA AU - Welsh, G AU - Huskisson, EC TI - Joint space in radiologically normal knees J2 - Br J Rheumatol PY - 1991 VL - 30 SP - 426 EP - 428 ER - TY - JOUR LB - 43. AU - Cooper, C AU - Cushnaghan, J AU - Kirwan, JR AU - Dieppe, PA AU - Rogers, J AU - McAlindon, T TI - Radiographic assessment of the knee joint in osteoarthritis J2 - Ann Rheum Dis PY - 1992 VL - 51 SP - 80 EP - 82 ER - TY - JOUR LB - 44. AU - Hochberg, MC TI - Quantitative radiography in osteoarthritis: analysis J2 - Baillieres Clin Rheumatol PY - 1996 VL - 10 SP - 421 EP - 428 ER - TY - JOUR LB - 45. AU - Wolfe, F AU - Lane, NE TI - The longterm outcome of osteoarthritis: rates and predictors of joint space narrowing in symptomatic patients with knee osteoarthritis J2 - J Rheumatol PY - 2002 VL - 29 SP - 139 EP - 146 ER - TY - JOUR LB - 46. AU - Barker, K AU - Lamb, SE AU - Toye, F AU - Jackson, S AU - Barrington, S TI - Association between radiographic joint space narrowing, function, pain and muscle power in severe osteoarthritis of the knee J2 - Clin Rehabil PY - 2004 VL - 18 SP - 793 EP - 800 ER - TY - JOUR LB - 47. AU - Bruyere, O AU - Honore, A AU - Rovati, LC AU - Giacovelli, G AU - Henrotin, YE AU - Seidel, L TI - Radiologic features poorly predict clinical outcomes in knee osteoarthritis J2 - Scand J Rheumatol PY - 2002 VL - 31 SP - 13 EP - 16 ER - TY - JOUR LB - 48. AU - Chang, CB AU - Han, I AU - Kim, SJ AU - Seong, SC AU - Kim, TK TI - Association between radiological findings and symptoms at the patellofemoral joint in advanced knee osteoarthritis J2 - J Bone Joint Surg Br PY - 2007 VL - 89 SP - 1324 EP - 1328 ER - TY - JOUR LB - 49. AU - Cicuttini, FM AU - Baker, J AU - Hart, DJ AU - Spector, TD TI - Association of pain with radiological changes in different compartments and views of the knee joint J2 - Osteoarthritis Cartilage PY - 1996 VL - 4 SP - 143 EP - 147 ER - TY - JOUR LB - 50. AU - Brandt, KD AU - Fife, RS AU - Braunstein, EM AU - Katz, B TI - Radiographic grading of the severity of knee osteoarthritis: relation of the Kellgren and Lawrence grade to a grade based on joint space narrowing, and correlation with arthroscopic evidence of articular cartilage degeneration J2 - Arthritis Rheum PY - 1991 VL - 34 SP - 1381 EP - 1386 ER - TY - JOUR LB - 51. AU - Bingham, C AU - Beary, J AU - Adami, S AU - Clauw, D AU - Cohen, S AU - Dougados, M TI - Significant joint space narrowing (JSN) in medial knee osteoarthritis (OA) is associated with increased joint symptoms: results of a 2-year randomized placebo-controlled study of risedronate J2 - Osteoarthritis Cartilage PY - 2004 VL - 12 SP - S142 ER - TY - JOUR LB - 52. AU - Bruyere, O AU - Pavelká, K AU - Rovati, LC AU - Gatterova, J AU - Giacovelli, G AU - Olejarova, M TI - Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials J2 - Osteoarthritis Cartilage PY - 2008 VL - 16 SP - 254 EP - 260 ER - TY - JOUR LB - 53. AU - Bruyere, O AU - Richy, F AU - Reginster, JY TI - Minimal joint space narrowing is a better predictor of the need for surgery than mean joint space narrowing: an 8-year prospective follow-up study in knee osteoarthritis J2 - Osteoarthritis Cartilage PY - 2004 VL - 12 SP - S54 ER - TY - JOUR LB - 54. AU - Cicuttini, FM AU - Jones, G AU - Forbes, A AU - Wluka, AE TI - Rate of cartilage loss at two years predicts subsequent total knee arthroplasty: a prospective study J2 - Ann Rheum Dis PY - 2004 VL - 63 SP - 1124 EP - 1127 ER - TY - JOUR LB - 55. AU - Altman, R AU - Brandt, K AU - Hochberg, M AU - Moskowitz, R TI - Design and conduct of clinical trials in patients with osteoarthritis J2 - Osteoarthritis Cartilage PY - 1996 VL - 4 SP - 217 EP - 243 ER - TY - JOUR LB - 56. AU - Botha-Scheepers, S AU - Kloppenburg, M AU - Kroon, HM AU - Hellio Le Graverand, MP AU - Breedveld, FC AU - Ravaud, P TI - Fixed-flexion knee radiography: the sensitivity to detect knee joint space narrowing in osteoarthritis J2 - Osteoarthritis Cartilage PY - 2007 VL - 15 SP - 350 EP - 353 ER - TY - JOUR LB - 57. AU - Chaisson, CE AU - Gale, DR AU - Gale, E AU - Kazis, L AU - Skinner, K AU - Felson, DT TI - Detecting radiographic knee osteoarthritis: what combination of views is optimal? J2 - Rheumatology PY - 2000 VL - 39 SP - 1218 EP - 1221 ER - TY - JOUR LB - 58. AU - Davies, AP AU - Calder, DA AU - Marshall, T AU - Glasgow, MM TI - Plain radiography in the degenerate knee. A case for change J2 - J Bone Joint Surg Br PY - 1999 VL - 81 SP - 632 EP - 635 ER - TY - JOUR LB - 59. AU - Pavelká, K AU - Bruyere, O AU - Rovati, LC AU - Olejarova, M AU - Giacovelli, G AU - Reginster, JY TI - Relief in mild-to-moderate pain is not a confounder in joint space narrowing assessment of full extension knee radiographs in recent osteoarthritis structure-modifying drug trials J2 - Osteoarthritis Cartilage PY - 2003 VL - 11 SP - 730 EP - 737 ER - TY - JOUR LB - 60. AU - Davies-Tuck, ML AU - Wluka, AE AU - Wang, Y AU - Teichtahl, AJ AU - Jones, G AU - Ding, C TI - The natural history of cartilage defects in people with knee osteoarthritis J2 - Osteoarthritis Cartilage PY - 2008 VL - 16 SP - 337 EP - 342 ER - TY - JOUR LB - 61. AU - Reichenbach, S AU - Sterchi, R AU - Scherer, M AU - Trelle, S AU - Burgi, E AU - Burgi, U TI - Meta-analysis: chondroitin for osteoarthritis of the knee or hip J2 - Ann Intern Med PY - 2007 VL - 146 SP - 580 EP - 590 ER - TY - JOUR LB - 62. AU - Towheed, TE AU - Maxwell, L AU - Anastassiades, TP AU - Shea, B AU - Houpt, J AU - Robinson, V TI - Glucosamine therapy for treating osteoarthritis J2 - Cochrane Database Syst Rev PY - 2005 ER - TY - JOUR LB - 63. AU - Owens, S AU - Wagner, P AU - Vangsness, CT, Jr. TI - Recent advances in glucosamine and chondroitin supplementation J2 - J Knee Surg PY - 2004 VL - 17 SP - 185 EP - 193 ER - TY - JOUR LB - 64. AU - Anderson, JW AU - Nicolosi, RJ AU - Borzelleca, JF TI - Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy J2 - Food Chem Toxicol PY - 2005 VL - 43 SP - 187 EP - 201 ER - TY - ELEC LB - 65. AU - MHRA TI - New drugs under intensive surveillance UR - www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con014660.pdf M1 - 15 September 2008 ER - TY - JOUR LB - 66. AU - Adebowale, A AU - Cox, DS AU - Liang, Z AU - Eddington, ND TI - Analysis of glucosamine and chondroitin sulfate content in marketed products and the Caco-2 permeability of chondroitin sulfate raw materials J2 - J Am Nutraceut Assoc PY - 2000 VL - 3 SP - 37 EP - 44 ER - TY - JOUR LB - 67. AU - Barnhill, JG AU - Fye, CL AU - Williams, DW AU - Reda, DJ AU - Harris, CL AU - Clegg, DO TI - Chondroitin product selection for the glucosamine/chondroitin arthritis intervention trial J2 - J Am Pharm Assoc (2003) PY - 2006 VL - 46 SP - 14 EP - 24 ER - TY - ELEC LB - 68. AU - Scottish Medicines Consortium TI - Glucosamine (Alateris) UR - www.scottishmedicines.org.uk/smc/5777.html M1 - 15 September 2008 ER - TY - ELEC LB - 69. AU - NHS Business Services Authority TI - Prescription Pricing Division UR - www.nhsbsa.nhs.uk/prescriptions M1 - 13 July 200 ER - TY - JOUR LB - 70. AU - Jordan, KM AU - Sawyer, S AU - Coakley, P AU - Smith, HE AU - Cooper, C AU - Arden, NK TI - The use of conventional and complementary treatments for knee osteoarthritis in the community J2 - Rheumatology (Oxford) PY - 2004 VL - 43 SP - 381 EP - 384 ER - TY - JOUR LB - 71. AU - Moher, D AU - Cook, DJ AU - Eastwood, S AU - Olkin, I AU - Rennie, D AU - Stroup, DF TI - Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses J2 - Lancet PY - 1999 VL - 354 SP - 1896 EP - 1900 ER - TY - GEN LB - 72. AU - Khan, KS AU - ter Riet, G AU - Glanville,, J AU - Sowden,, A AU - Kleijnen, J TI - Undertaking systematic reviews of research on effectiveness: CRD’s guidance for those carrying out and commissioning reviews ET - 2nd PY - 2001 ER - TY - JOUR LB - 73. AU - Poolsup, N AU - Suthisisang, C AU - Channark, P AU - Kittikulsuth, W TI - Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials J2 - Ann Pharmacother PY - 2005 VL - 39 SP - 1080 EP - 1087 ER - TY - JOUR LB - 74. AU - Bana, G AU - Jamard, B AU - Verrouil, E AU - Mazieres, B TI - Chondroitin sulfate in the management of hip and knee osteoarthritis: an overview J2 - Adv Pharmacol PY - 2006 VL - 53 SP - 507 EP - 522 ER - TY - JOUR LB - 75. AU - Richy, F AU - Bruyere, O AU - Ethgen, O AU - Cucherat, M AU - Henrotin, Y AU - Reginster, JY TI - Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis J2 - Arch Intern Med PY - 2003 VL - 163 SP - 1514 EP - 1522 ER - TY - JOUR LB - 76. AU - Reginster, JY AU - Deroisy, R AU - Rovati, LC AU - Lee, RL AU - Lejeune, E AU - Bruyere, O TI - Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial J2 - Lancet PY - 2001 VL - 357 SP - 251 EP - 256 ER - TY - JOUR LB - 77. AU - Pavelká, K AU - Gatterova, J AU - Olejarova, M AU - Machacek, S AU - Giacovelli, G AU - Rovati, LC TI - Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study J2 - Arch Intern Med PY - 2002 VL - 162 SP - 2113 EP - 2123 ER - TY - JOUR LB - 78. AU - Cibere, J AU - Kopec, JA AU - Thorne, A AU - Singer, J AU - Canvin, J AU - Robinson, DB TI - Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis J2 - Arthritis Rheum PY - 2004 VL - 51 SP - 738 EP - 745 ER - TY - JOUR LB - 79. AU - Crolle, G AU - D’Este, E TI - Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation J2 - Curr Med Res Opin PY - 1980 VL - 7 SP - 104 EP - 109 ER - TY - JOUR LB - 80. AU - D’Ambrosio, E AU - Casa, B AU - Bompani, R AU - Scali, G AU - Scali, M TI - Glucosamine sulphate: a controlled clinical investigation in arthrosis J2 - Pharmatherapeutica PY - 1981 VL - 2 SP - 504 EP - 508 ER - TY - JOUR LB - 81. AU - Drovanti, A AU - Bignamini, AA AU - Rovati, AL TI - Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation J2 - Clin Ther PY - 1980 VL - 3 SP - 260 EP - 272 ER - TY - JOUR LB - 82. AU - Herrero-Beaumont, G AU - Ivorra, JA AU - Del Carmen, TM AU - Blanco, FJ AU - Benito, P AU - Martin-Mola, E TI - Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator J2 - Arthritis Rheum PY - 2007 VL - 56 SP - 555 EP - 567 ER - TY - JOUR LB - 83. AU - Houpt, JB AU - McMillan, R AU - Wein, C AU - Paget-Dellio, SD TI - Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee J2 - J Rheumatol PY - 1999 VL - 26 SP - 2423 EP - 2430 ER - TY - JOUR LB - 84. AU - Hughes, R AU - Carr, A TI - A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee J2 - Rheumatology PY - 2002 VL - 41 SP - 279 EP - 284 ER - TY - JOUR LB - 85. AU - McAlindon, T AU - Formica, M AU - LaValley, M AU - Lehmer, M AU - Kabbara, K TI - Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial J2 - Am J Med PY - 2004 VL - 117 SP - 643 EP - 649 ER - TY - JOUR LB - 86. AU - Müller-Fassbender, H AU - Bach, GL AU - Haase, W AU - Rovati, LC AU - Setnikar, I TI - Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee J2 - Osteoarthritis Cartilage PY - 1994 VL - 2 SP - 61 EP - 69 ER - TY - JOUR LB - 87. AU - Noack, W AU - Fischer, M AU - Forster, KK AU - Rovati, LC AU - Setnikar, I TI - Glucosamine sulfate in osteoarthritis of the knee J2 - Osteoarthritis Cartilage PY - 1994 VL - 2 SP - 51 EP - 59 ER - TY - JOUR LB - 88. AU - Pujalte, JM AU - Llavore, EP AU - Ylescupidez, FR TI - Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis J2 - Curr Med Res Opin PY - 1980 VL - 7 SP - 110 EP - 114 ER - TY - JOUR LB - 89. AU - Qiu, GX AU - Gao, SN AU - Giacovelli, G AU - Rovati, L AU - Setnikar, I TI - Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis J2 - Arzneimittelforschung PY - 1998 VL - 48 SP - 469 EP - 474 ER - TY - JOUR LB - 90. AU - Reichelt, A AU - Forster, KK AU - Fischer, M AU - Rovati, LC AU - Setnikar, I TI - Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee – a randomized, placebo-controlled, double-blind study J2 - Arzneimittelforschung/Drug Res PY - 1994 VL - 44 SP - 75 EP - 80 ER - TY - JOUR LB - 91. AU - Rindone, JP AU - Hiller, D AU - Collacott, E AU - Nordhaugen, N AU - Arriola, G TI - Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee J2 - West J Med PY - 2000 VL - 172 SP - 91 EP - 94 ER - TY - JOUR LB - 92. AU - Rovati, L TI - The clinical profile of glucosamine sulfate as a selective symptom-modifying drug in osteoarthritis: current data and perspectives J2 - Osteoarthritis Cartilage PY - 1997 VL - 5 SP - 72 ER - TY - JOUR LB - 93. AU - Usha, PR TI - Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis J2 - Clin Drug Investig PY - 2004 VL - 24 SP - 353 EP - 363 ER - TY - JOUR LB - 94. AU - Vajaradul, Y TI - Double-blind clinical evaluation of intra-articular glucosamine in outpatients with gonarthrosis J2 - Clin Ther PY - 1981 VL - 3 SP - 336 EP - 343 ER - TY - JOUR LB - 95. AU - Vaz, LA TI - Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients J2 - Curr Med Res Opin PY - 1982 VL - 8 SP - 145 EP - 149 ER - TY - JOUR LB - 96. AU - Zenk, JL TI - The effects of milk protein concentrate on the symptoms of osteoarthritis in adults: an exploratory, randomized, double-blind, placebo-controlled trial J2 - Curr Ther Res – Clin Exp PY - 2002 VL - 63 SP - 430 EP - 442 ER - TY - JOUR LB - 97. AU - Alekseeva, LI AU - Benevolenskaia, LI AU - Nasonov, EL AU - Chichasova, NV AU - Kariakin, AN TI - Structum (chondroitin sulfate) – a new agent for the treatment of osteoarthrosis J2 - Ter Arkh PY - 1999 VL - 71 SP - 51 EP - 53 ER - TY - JOUR LB - 98. AU - Bourgeois, P AU - Chales, G AU - Dehais, J AU - Delcambre, B AU - Kuntz, JL AU - Rozenberg, S TI - Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 400 mg/day vs placebo J2 - Osteoarthritis Cartilage PY - 1998 VL - 6 IS - Suppl. A SP - 25 EP - 30 ER - TY - JOUR LB - 99. AU - Bucsi, L AU - Poor, G TI - Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis J2 - Osteoarthritis Cartilage PY - 1998 VL - 6 IS - Suppl. 6 ER - TY - JOUR LB - 100. AU - Conrozier, T AU - Vignon, E TI - Die Wirkung von Chondroitinsulfat bei der Behandlung der Hüftgelenksarthrose: eine Doppelblindstudie gegen Placebo J2 - Litera Rheumatol PY - 1992 VL - 14 SP - 69 EP - 75 ER - TY - JOUR LB - 101. AU - Fleisch, A AU - Melin, C AU - Imhoff, A AU - Hodler, J AU - Kissling, R TI - A one-year randomized, double-blind, placebo-controlled study with oral chondroitin sulfate in patients with knee osteoarthritis J2 - Osteoarthritis Cartilage PY - 1997 VL - 5 SP - S70 ER - TY - JOUR LB - 102. AU - Kahan, A AU - Vignon, E AU - Uebelhart, D AU - Reginster, JY TI - A randomized controlled trial with chondroitin sulfate involving over 600 patients: STOPP (STudy on Osteoarthritis Progression Prevention) J2 - Osteoporosis Int PY - 2007 VL - 18 SP - S14 EP - S15 ER - TY - JOUR LB - 103. AU - Kerzberg, EM AU - Roldan, EJ AU - Castelli, G AU - Huberman, ED TI - Combination of glycosaminoglycans and acetylsalicylic acid in knee osteoarthrosis J2 - Scand J Rheumatol PY - 1987 VL - 16 SP - 377 EP - 380 ER - TY - JOUR LB - 104. AU - L’Hirondel, J TI - Doppelblind-Studie mit oral verabreichtem Chondroitinsulfat gegen Placebo bei der tibiofemoralen Gonarthrose (125 patients) J2 - Litera Rheumatol PY - 1992 VL - 14 SP - 77 EP - 84 ER - TY - JOUR LB - 105. AU - Mazieres, B AU - Loyau, G AU - Menkes, CJ AU - Valat, JP AU - Dreiser, RL AU - Charlot, J TI - Chondroitin sulfate in the treatment of gonarthrosis and coxarthrosis. 5-months result of a multicenter double-blind controlled prospective study using placebo J2 - Rev Rhum Mal Osteoartic PY - 1992 VL - 59 SP - 466 EP - 472 ER - TY - JOUR LB - 106. AU - Mazieres, B AU - Combe, B AU - Phan, VA AU - Tondut, J AU - Grynfeltt, M TI - Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study J2 - J Rheumatol PY - 2001 VL - 28 SP - 173 EP - 181 ER - TY - JOUR LB - 107. AU - Mazieres, B AU - Hucher, M AU - Zaim, M AU - Garnero, P TI - Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study J2 - Ann Rheum Dis PY - 2007 VL - 66 SP - 639 EP - 645 ER - TY - JOUR LB - 108. AU - Michel, BA AU - Stucki, G AU - Frey, D AU - De, VF AU - Vignon, E AU - Bruehlmann, P TI - Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial J2 - Arthritis Rheum PY - 2005 VL - 52 SP - 779 EP - 786 ER - TY - JOUR LB - 109. AU - Morreale, P AU - Manopulo, R AU - Galati, M AU - Boccanera, L AU - Saponati, G AU - Bocchi, L TI - Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis J2 - J Rheumatol PY - 1996 VL - 23 SP - 1385 EP - 1391 ER - TY - JOUR LB - 110. AU - Nasonova, VA AU - Alekseeva, LI AU - Arkhangel’skaia, GS AU - Davydova, AF AU - Karmil’tseva, EA AU - Kogan, KM TI - Results of the multicenter clinical trial of structum preparation in Russia J2 - Ter Arkh PY - 2001 VL - 73 SP - 84 EP - 87 ER - TY - JOUR LB - 111. AU - Pavelká, K AU - Manopulo, R AU - Bucsi, L TI - Double-blind, dose-effect study of oral chondroitin 4 & 6 sulfate 1200 mg, 800 mg, 200 mg, and placebo in the treatment of knee osteoarthritis J2 - Litera Rheumatol PY - 1999 VL - 24 SP - 21 EP - 30 ER - TY - JOUR LB - 112. AU - Rovetta, G TI - Galactosaminoglycuronoglycan sulfate (matrix) in therapy of tibiofibular osteoarthritis of the knee J2 - Drugs Exp Clin Res PY - 1991 VL - 17 SP - 53 EP - 57 ER - TY - JOUR LB - 113. AU - Soroka, NF AU - Chyzh, KA TI - Clinical efficiency and pharmacoeconomical evaluation of treatment by chondroitinsulphate (Structumc) in patients with primary osteoarthritis (POA) J2 - Ann Rheum Dis PY - 2002 VL - 61 SP - AB0289 ER - TY - JOUR LB - 114. AU - Uebelhart, D AU - Thonar, EJ AU - Delmas, PD AU - Chantraine, A AU - Vignon, E TI - Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study J2 - Osteoarthritis Cartilage PY - 1998 VL - 6 IS - Suppl. A SP - 39 EP - 46 ER - TY - JOUR LB - 115. AU - Uebelhart, D AU - Knussel, O AU - Theiler, R TI - Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study J2 - Schweiz Med Wochenschr PY - 1999 VL - 129 SP - 1174 ER - TY - JOUR LB - 116. AU - Uebelhart, D AU - Malaise, M AU - Marcolongo, R AU - DeVathaire, F AU - Piperno, M AU - Mailleux, E TI - Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo J2 - Osteoarthritis Cartilage PY - 2004 VL - 12 SP - 269 EP - 276 ER - TY - JOUR LB - 117. AU - Clegg, DO AU - Reda, DJ AU - Harris, CL AU - Klein, MA AU - O’Dell, JR AU - Hooper, MM TI - Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis J2 - New Engl J Med PY - 2006 VL - 354 SP - 795 EP - 808 ER - TY - JOUR LB - 118. AU - Cohen, M AU - Wolfe, R AU - Mai, T AU - Lewis, D TI - A randomized, double blind, placebo controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee. [erratum appears in J Rheumatol 2003 30:2512] J2 - J Rheumatol PY - 2003 VL - 30 SP - 523 EP - 528 ER - TY - JOUR LB - 119. AU - Das, A, Jr. AU - Hammad, TA TI - Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis J2 - Osteoarthritis Cartilage PY - 2000 VL - 8 SP - 343 EP - 350 ER - TY - JOUR LB - 120. AU - Rai, J TI - Efficacy of chondroitin sulfate and glucosamine sulfate in the progression of symptomatic knee osteoarthritis: a randomized, placebo-controlled, double blind study J2 - Bull Postgrad Inst Med Educ Res, Chandigarh PY - 2004 VL - 38 SP - 18 EP - 22 ER - TY - JOUR LB - 121. AU - Conrozier, T TI - Anti-arthrosis treatments: efficacy and tolerance of chondroitin sulfates (CS 4&6) J2 - Presse Med PY - 1998 VL - 27 SP - 1862 EP - 1865 ER - TY - JOUR LB - 122. AU - Messier, SP AU - Mihalko, S AU - Loeser, RF AU - Legault, C AU - Jolla, J AU - Pfruender, J TI - Glucosamine/chondroitin combined with exercise for the treatment of knee osteoarthritis: a preliminary study J2 - Osteoarthritis Cartilage PY - 2007 VL - 15 SP - 1256 EP - 1266 ER - TY - JOUR LB - 123. AU - Kawasaki, T AU - Kurosawa, H AU - Ikeda, H AU - Kim, SG AU - Osawa, A AU - Takazawa, Y TI - Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial J2 - J Bone Miner Metab PY - 2008 VL - 26 SP - 279 EP - 287 ER - TY - JOUR LB - 124. AU - Sawitzke, AD AU - Shi, H AU - Finco, MF AU - Dunlop, DD AU - Bingham, CO, III AU - Harris, CL TI - The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial J2 - Arthritis Rheum PY - 2008 VL - 58 SP - 3183 EP - 3191 ER - TY - JOUR LB - 125. AU - Braham, R AU - Dawson, B AU - Goodman, C TI - The effect of glucosamine supplementation on people experiencing regular knee pain J2 - Br J Sports Med PY - 2003 VL - 37 SP - 45 EP - 49 ER - TY - JOUR LB - 126. AU - Frestedt, JL AU - Walsh, M AU - Kuskowski, MA AU - Zenk, JL TI - A natural mineral supplement provides relief from knee osteoarthritis symptoms: a randomized controlled pilot trial J2 - Nutr J PY - 2008 VL - 7 SP - 9 ER - TY - JOUR LB - 127. AU - Mehta, K AU - Gala, J AU - Bhasale, S AU - Naik, S AU - Modak, M AU - Thakur, H TI - Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351] J2 - BMC Complement Altern Med PY - 2007 VL - 7 SP - 34 ER - TY - JOUR LB - 128. AU - Zhang, WB AU - Zhuang, CY AU - Li, JM AU - Yang, ZP AU - Chen, XL TI - Efficacy and safety evaluation of glucosamine hydrochloride in the treatment of osteoarthritis J2 - Chung-Hua Wai Ko Tsa Chih [Chinese Journal of Surgery] PY - 2007 VL - 45 SP - 998 EP - 1001 ER - TY - JOUR LB - 129. AU - Debi, R AU - Robinson, D AU - Agar, G AU - Halperin, N TI - GAG for osteoarthritis of the knee – a prospective study J2 - Harefuah PY - 2000 VL - 138 SP - 451 EP - 453 ER - TY - JOUR LB - 130. AU - Leffler, CT AU - Philippi, AF AU - Leffler, SG AU - Mosure, JC AU - Kim, PD TI - Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study J2 - Military Med PY - 1999 VL - 164 SP - 85 EP - 91 ER - TY - JOUR LB - 131. AU - Nguyen, P AU - Mohamed, SE AU - Gardiner, D AU - Salinas, T TI - A randomized double-blind clinical trial of the effect of chondroitin sulfate and glucosamine hydrochloride on temporomandibular joint disorders: a pilot study J2 - Cranio PY - 2001 VL - 19 SP - 130 EP - 139 ER - TY - JOUR LB - 132. AU - Stumpf, JL AU - Lin, SW TI - Effect of glucosamine on glucose control J2 - Ann Pharmacother PY - 2006 VL - 40 SP - 694 EP - 698 ER - TY - JOUR LB - 133. AU - Scroggie, DA TI - The effect of glucosamine-chondroitin supplementation on glycosylated hemoglobin levels in patients with type 2 diabetes mellitus: A placebo-controlled, double-blinded, randomized clinical trial J2 - Arch Intern Med PY - 2003 VL - 163 SP - 1587 EP - 1590 ER - TY - JOUR LB - 134. AU - Knudsen, JF AU - Sokol, GH TI - Potential glucosamine–warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database J2 - Pharmacotherapy PY - 2008 VL - 28 SP - 540 EP - 548 ER - TY - JOUR LB - 135. AU - Adverse Drug Reactions Advisory Committee (ADRAC), Adverse Drug Reactions Unit (ADRU TI - Interaction between glucosamine and warfarin J2 - Austr Adverse Drug React Bull PY - 2008 VL - 27 SP - 3 ER - TY - ELEC LB - 136. AU - BBC News TI - Arthritis remedy theory for death PY - 2007 UR - http://news.bbc.co.uk/1/hi/scotland/tayside_and_central/7131026.stm M1 - 27 November 2008 ER - TY - JOUR LB - 137. AU - Hurley, MV AU - Walsh, NE AU - Mitchell, HL AU - Pimm, TJ AU - Williamson, E AU - Jones, RH TI - Economic evaluation of a rehabilitation program integrating exercise, self-management, and active coping strategies for chronic knee pain J2 - Arthritis Rheum PY - 2007 VL - 57 SP - 1220 EP - 1229 ER - TY - JOUR LB - 138. AU - Grootendorst, P AU - Marshall, D AU - Pericak, D AU - Bellamy, N AU - Feeny, D AU - Torrance, GW TI - A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee J2 - J Rheumatol PY - 2007 VL - 34 SP - 534 EP - 542 ER - TY - JOUR LB - 139. AU - Barton, G AU - Sach, T AU - Jenkinson, C AU - Avery, A AU - Docherty, M AU - Muir, K TI - Do estimates of cost–utility based on the EQ-5D differ from those based on the mapping of utility scores? J2 - Health Qual Life Outcomes PY - 2008 VL - 6 SP - 51 ER - TY - GEN LB - 140. AU - Office for National Statistics TI - Health Statistics Quarterly CY - Newport PB - Office for National Statistics PY - 2007 ER - TY - JOUR LB - 141. AU - Nunez, M AU - Nunez, E AU - del Val, JL AU - Ortega, R AU - Segur, JM AU - Hernandez, MV TI - Health-related quality of life in patients with osteoarthritis after total knee replacement: factors influencing outcomes at 36 months of follow-up J2 - Osteoarthritis Cartilage PY - 2007 VL - 15 SP - 1001 EP - 1007 ER - TY - GEN LB - 142. AU - Department of Health TI - National Tarriff 2006–7 CY - London PB - Department of Health PY - 2006 ER - TY - ELEC LB - 143. AU - Rotta Pharmaceuticals TI - DONA: glucosamine sulfate PY - 2008 UR - www.donausa.com/order.php M1 - 13 July 2009 ER - TY - ELEC LB - 144. AU - BMJ Group and RPS Publishing TI - British national formulary 55 PY - 2008 UR - http://bnf.org/bnf/bnf/current/index.htm M1 - 15 January 2008 ER - TY - ELEC LB - 145. AU - HM Treasury TI - The green book PY - 2007 UR - www.hm-treasury.gov.uk/data_data_greenbook_index.htm M1 - 13 July 2009 ER - TY - BOOK LB - 146. AU - Briggs, A AU - Claxton, K AU - Sculpher, M TI - Decision modelling for health economic evaluation CY - Oxford PB - Oxford University Press PY - 2006 ER - TY - ELEC LB - 147. AU - Department of Health TI - NHS reference costs 2004 PY - 2005 UR - http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4105545 M1 - 27 November 2008 ER - TY - JOUR LB - 148. AU - Fioravanti, A AU - Collodel, G TI - In vitro effects of chondroitin sulfate J2 - Adv Pharmacol PY - 2006 VL - 53 SP - 449 EP - 465 ER - TY - JOUR LB - 149. AU - Volpi, N TI - Chondroitin sulphate for the treatment of osteoarthritis J2 - Curr Med Chem PY - 2005 VL - 4 SP - 221 EP - 234 ER - TY - JOUR LB - 150. AU - Laverty, S AU - Sandy, JD AU - Celeste, C AU - Vachon, P AU - Marier, JF AU - Plaas, AH TI - Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses J2 - Arthritis Rheum PY - 2005 VL - 52 SP - 181 EP - 191 ER - TY - JOUR LB - 151. AU - Adebowale, A AU - Du, J AU - Liang, Z AU - Leslie, JL AU - Eddington, ND TI - The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs J2 - Biopharm Drug Dispos PY - 2002 VL - 23 SP - 217 EP - 225 ER - TY - JOUR LB - 152. AU - Setnikar, I TI - Absorption, distribution, metabolism and excretion of glucosamine sulfate: a review J2 - Arzneimittelforschung/Drug Res PY - 2001 VL - 51 SP - 699 EP - 725 ER - TY - JOUR LB - 153. AU - Setnikar, I AU - Giachetti, C AU - Zanolo, G TI - Absorption, distribution and excretion of radioactivity after a single intravenous or oral administration of [14C] glucosamine to the rat J2 - Pharmatherapeutica PY - 1984 VL - 3 SP - 538 EP - 550 ER - TY - JOUR LB - 154. AU - Setnikar, I TI - Pharmacokinetics of glucosamine in the dog and in man J2 - Arzneimittelforschung/Drug Res PY - 1986 VL - 36 SP - 729 EP - 735 ER - TY - JOUR LB - 155. AU - Setnikar, I TI - Absorption, distribution and excretion of radioactivity after single intravenous or oral administration of D-[U-14C] glucose to the rat J2 - Acta Ther PY - 1986 VL - 12 SP - 353 EP - 371 ER - TY - JOUR LB - 156. AU - Setnikar, I AU - Palumbo, R AU - Canali, S AU - Zanolo, G TI - Pharmacokinetics of glucosamine in man J2 - Arzneimittelforschung/Drug Res PY - 1993 VL - 43 SP - 1109 EP - 1113 ER - TY - JOUR LB - 157. AU - Biggee, BA AU - Blinn, CM AU - McAlindon, TE AU - Nuite, M AU - Silbert, JE TI - Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness J2 - Ann Rheum Dis PY - 2006 VL - 65 SP - 222 EP - 226 ER - TY - JOUR LB - 158. AU - Basak, M AU - Joseph, S AU - Joshi, S AU - Sawant, S TI - Comparative bioavailability of a novel timed release and powder-filled glucosamine sulfate formulation – a multi-dose, randomized, crossover study J2 - Int J Clin Pharmacol Ther PY - 2004 VL - 42 SP - 597 EP - 601 ER - TY - JOUR LB - 159. AU - Persiani, S AU - Rotini, R AU - Trisolino, G AU - Rovati, LC AU - Locatelli, M AU - Paganini, D TI - Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose J2 - Osteoarthritis Cartilage PY - 2007 VL - 15 SP - 764 EP - 772 ER - TY - JOUR LB - 160. AU - Persiani, S AU - Roda, E AU - Rovati, LC AU - Locatelli, M AU - Giacovelli, G AU - Roda, A TI - Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man J2 - Osteoarthritis Cartilage PY - 2005 VL - 13 SP - 1041 EP - 1049 ER - TY - JOUR LB - 161. AU - Nakayama, Y AU - Narita, T AU - Mori, A AU - Uesaka, S AU - Miyazaki, K AU - Ito, H TI - The effects of age and sex on chondroitin sulfates in normal synovial fluid J2 - Arthritis Rheum PY - 2002 VL - 46 SP - 2105 EP - 2108 ER - TY - JOUR LB - 162. AU - Volpi, N TI - Oral bioavailability of chondroitin sulfate (Condrosulf) and its constituents in healthy male volunteers J2 - Osteoarthritis Cartilage PY - 2002 VL - 10 SP - 768 EP - 777 ER - TY - JOUR LB - 163. AU - Volpi, N TI - Oral absorption and bioavailability of ichthyic origin chondroitin sulfate in healthy male volunteers J2 - Osteoarthritis Cartilage PY - 2003 VL - 11 SP - 433 EP - 441 ER - TY - JOUR LB - 164. AU - Ronca, F AU - Palmieri, L AU - Panicucci, P AU - Ronca, G TI - Anti-inflammatory activity of chondroitin sulfate J2 - Osteoarthritis Cartilage PY - 1998 VL - 6 IS - Suppl. A SP - 14 EP - 21 ER - TY - JOUR LB - 165. AU - Ebube, NK AU - Mark, W AU - Hahm, H TI - Preformulation studies and characterization of proposed chondroprotective agents: glucosamine HCl and chondroitin sulfate J2 - Pharm Dev Technol PY - 2002 VL - 7 SP - 457 EP - 469 ER - TY - JOUR LB - 166. AU - Dodge, GR AU - Jimenez, SA TI - Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes J2 - Osteoarthritis Cartilage PY - 2003 VL - 11 SP - 424 EP - 432 ER - TY - JOUR LB - 167. AU - Noyszewski, EA AU - Wroblewski, K AU - Dodge, GR AU - Kudchodkar, S AU - Beers, J AU - Sarma, AV TI - Preferential incorporation of glucosamine into the galactosamine moieties of chondroitin sulfates in articular cartilage explants J2 - Arthritis Rheum PY - 2001 VL - 44 SP - 1089 EP - 1095 ER - TY - JOUR LB - 168. AU - Derfoul, A AU - Miyoshi, AD AU - Freeman, DE AU - Tuan, RS TI - Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation J2 - Osteoarthritis Cartilage PY - 2007 VL - 15 SP - 646 EP - 655 ER - TY - JOUR LB - 169. AU - Varghese, S AU - Theprungsirikul, P AU - Sahani, S AU - Hwang, N AU - Yarema, KJ AU - Elisseeff, JH TI - Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression J2 - Osteoarthritis Cartilage PY - 2007 VL - 15 SP - 59 EP - 68 ER - TY - JOUR LB - 170. AU - Nishimoto, S AU - Takagi, M AU - Wakitani, S AU - Nihira, T AU - Yoshida, T TI - Effect of chondroitin sulfate and hyaluronic acid on gene expression in a three-dimensional culture of chondrocytes J2 - J Biosci Bioeng PY - 2005 VL - 100 SP - 123 EP - 126 ER - TY - JOUR LB - 171. AU - Mroz, PJ AU - Silbert, JE TI - Use of 3H-glucosamine and 35S-sulfate with cultured human chondrocytes to determine the effect of glucosamine concentration on formation of chondroitin sulfate J2 - Arthritis Rheum PY - 2004 VL - 50 SP - 3574 EP - 3579 ER - TY - JOUR LB - 172. AU - Kim, MM AU - Mendis, E AU - Rajapakse, N AU - Kim, SK TI - Glucosamine sulfate promotes osteoblastic differentiation of MG-63 cells via anti-inflammatory effect J2 - Bioorg Med Chem Lett PY - 2007 VL - 17 SP - 1938 EP - 1942 ER - TY - JOUR LB - 173. AU - Uitterlinden, EJ AU - Jahr, H AU - Koevoet, JL AU - Jenniskens, YM AU - Bierma-Zeinstra, SM AU - DeGroot, J TI - Glucosamine decreases expression of anabolic and catabolic genes in human osteoarthritic cartilage explants J2 - Osteoarthritis Cartilage PY - 2006 VL - 14 SP - 250 EP - 257 ER - TY - JOUR LB - 174. AU - Piperno, M AU - Reboul, P AU - Hellio Le Graverand, MP AU - Peschard, MJ AU - Annefeld, M AU - Richard, M TI - Glucosamine sulfate modulates dysregulated activities of human osteoarthritic chondrocytes in vitro J2 - Osteoarthritis Cartilage PY - 2000 VL - 8 SP - 207 EP - 212 ER - TY - JOUR LB - 175. AU - Monfort, J AU - Nacher, M AU - Montell, E AU - Vila, J AU - Verges, J AU - Benito, P TI - Chondroitin sulfate and hyaluronic acid (500–730 kDa) inhibit stromelysin-1 synthesis in human osteoarthritic chondrocytes J2 - Drugs Exp Clin Res PY - 2005 VL - 31 SP - 71 EP - 76 ER - TY - JOUR LB - 176. AU - Tat, SK AU - Pelletier, JP AU - Verges, J AU - Lajeunesse, D AU - Montell, E AU - Fahmi, H TI - Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study J2 - Arthritis Res Ther PY - 2007 VL - 9 SP - R117 ER - TY - JOUR LB - 177. AU - Cibere, J AU - Thorne, A AU - Kopec, JA AU - Singer, J AU - Canvin, J AU - Robinson, DB TI - Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers J2 - J Rheumatol PY - 2005 VL - 32 SP - 896 EP - 902 ER - TY - JOUR LB - 178. AU - Ilic, MZ AU - Martinac, B AU - Handley, CJ TI - Effects of long-term exposure to glucosamine and mannosamine on aggrecan degradation in articular cartilage J2 - Osteoarthritis Cartilage PY - 2003 VL - 11 SP - 613 EP - 622 ER - TY - JOUR LB - 179. AU - Sandy, JD AU - Gamett, D AU - Thompson, V AU - Verscharen, C TI - Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine J2 - Biochem J PY - 1998 VL - 335 IS - Pt 1 SP - 59 EP - 66 ER - TY - JOUR LB - 180. AU - Sandy, JD AU - Thompson, V AU - Verscharen, C AU - Gamett, D TI - Chondrocyte-mediated catabolism of aggrecan: evidence for a glycosylphosphatidylinositol-linked protein in the aggrecanase response to interleukin-1 or retinoic acid J2 - Arch Biochem Biophys PY - 1999 VL - 367 SP - 258 EP - 264 ER - TY - JOUR LB - 181. AU - Tiku, ML AU - Narla, H AU - Jain, M AU - Yalamanchili, P TI - Glucosamine prevents in vitro collagen degradation in chondrocytes by inhibiting advanced lipoxidation reactions and protein oxidation J2 - Arthritis Res Ther PY - 2007 VL - 9 SP - R76 ER - TY - JOUR LB - 182. AU - Jomphe, C AU - Gabriac, M AU - Hale, TM AU - Heroux, L AU - Trudeau, LE AU - Deblois, D TI - Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappaB in interleukin-1beta-stimulated chondrocytes J2 - Basic Clin Pharmacol Toxicol PY - 2008 VL - 102 SP - 59 EP - 65 ER - TY - JOUR LB - 183. AU - Largo, R AU - Alvarez-Soria, MA AU - Diez-Ortego, I AU - Calvo, E AU - Sanchez-Pernaute, O AU - Egido, J TI - Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes J2 - Osteoarthritis Cartilage PY - 2003 VL - 11 SP - 290 EP - 298 ER - TY - JOUR LB - 184. AU - Pelletier, JP AU - Mineau, F AU - Ranger, P AU - Tardif, G AU - Martel-Pelletier, J TI - The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation J2 - Osteoarthritis Cartilage PY - 1996 VL - 4 SP - 77 EP - 84 ER - TY - JOUR LB - 185. AU - Blanco, FJ AU - Guitian, R AU - Vazquez-Martul, E AU - de Toro, FJ AU - Galdo, F TI - Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology J2 - Arthritis Rheum PY - 1998 VL - 41 SP - 284 EP - 289 ER - TY - JOUR LB - 186. AU - Chan, PS AU - Caron, JP AU - Rosa, GJ AU - Orth, MW TI - Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants J2 - Osteoarthritis Cartilage PY - 2005 VL - 13 SP - 387 EP - 394 ER - TY - JOUR LB - 187. AU - Chan, PS AU - Caron, JP AU - Orth, MW TI - Short-term gene expression changes in cartilage explants stimulated with interleukin beta plus glucosamine and chondroitin sulfate J2 - J Rheumatol PY - 2006 VL - 33 SP - 1329 EP - 1340 ER - TY - JOUR LB - 188. AU - Huser, CA AU - Davies, ME TI - Effect of a glucosamine derivative on impact-induced chondrocyte apoptosis in vitro. A preliminary report J2 - Osteoarthritis Cartilage PY - 2008 VL - 16 SP - 125 EP - 128 ER - TY - JOUR LB - 189. AU - Caraglia, M AU - Beninati, S AU - Giuberti, G AU - D’Alessandro, AM AU - Lentini, A AU - Abbruzzese, A TI - Alternative therapy of earth elements increases the chondroprotective effects of chondroitin sulfate in mice J2 - Exp Mol Med PY - 2005 VL - 37 SP - 476 EP - 481 ER - TY - JOUR LB - 190. AU - Lippiello, L TI - Glucosamine and chondroitin sulfate: biological response modifiers of chondrocytes under simulated conditions of joint stress J2 - Osteoarthritis Cartilage PY - 2003 VL - 11 SP - 335 EP - 342 ER - TY - JOUR LB - 191. AU - Nerucci, F AU - Fioravanti, A AU - Cicero, MR AU - Collodel, G AU - Marcolongo, R TI - Effects of chondroitin sulfate and interleukin-1beta on human chondrocyte cultures exposed to pressurization: a biochemical and morphological study J2 - Osteoarthritis Cartilage PY - 2000 VL - 8 SP - 279 EP - 287 ER - TY - JOUR LB - 192. AU - Nimni, ME TI - Chondroitin sulfate and sulfur containing chondroprotective agents: is there a basis for their pharmacological action? J2 - Curr Rheumatol Rev PY - 2006 VL - 2 SP - 137 EP - 149 ER - TY - JOUR LB - 193. AU - van der Kraan, PM TI - High susceptibility of human articular cartilage glycosaminoglycan synthesis to changes in inorganic sulfate availability J2 - J Orthop Res PY - 1990 VL - 8 SP - 565 EP - 571 ER - TY - JOUR LB - 194. AU - Hoffer, LJ AU - Kaplan, LN AU - Hamadeh, MJ AU - Grigoriu, AC AU - Baron, M TI - Sulfate could mediate the therapeutic effect of glucosamine sulfate J2 - Metabolism PY - 2001 VL - 50 SP - 767 EP - 770 ER - TY - JOUR LB - 195. AU - Cordoba, F AU - Nimni, ME TI - Chondroitin sulfate and other sulfate containing chondroprotective agents may exhibit their effects by overcoming a deficiency of sulfur amino acids J2 - Osteoarthritis Cartilage PY - 2003 VL - 11 SP - 228 EP - 230 ER - TY - JOUR LB - 196. AU - Ameye, LG AU - Chee, WS TI - Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence J2 - Arthritis Res Ther PY - 2006 VL - 8 SP - R127 ER - TY - JOUR LB - 197. AU - Biggee, BA AU - McAlindon, T TI - Glucosamine for osteoarthritis: part I, review of the clinical evidence J2 - Med Health, Rhode Island PY - 2004 VL - 87 SP - 176 EP - 179 ER - TY - JOUR LB - 198. AU - Bjordal, JM AU - Klovning, A AU - Ljunggren, AE AU - Slordal, L TI - Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials J2 - Eur J Pain PY - 2007 VL - 11 SP - 125 EP - 138 ER - TY - JOUR LB - 199. AU - Clayton, JJ TI - Nutraceuticals in the management of osteoarthritis J2 - Orthopedics PY - 2007 VL - 30 SP - 624 EP - 629 ER - TY - JOUR LB - 200. AU - Distler, J AU - Anguelouch, A TI - Evidence-based practice: review of clinical evidence on the efficacy of glucosamine and chondroitin in the treatment of osteoarthritis J2 - J Am Acad Nurse Pract PY - 2006 VL - 18 SP - 487 EP - 493 ER - TY - JOUR LB - 201. AU - Felson, DT AU - McAlindon, TE TI - Glucosamine and chondroitin for osteoarthritis: to recommend or not to recommend? J2 - Arthritis Care Res PY - 2000 VL - 13 SP - 179 EP - 182 ER - TY - JOUR LB - 202. AU - Leeb, BF AU - Schweitzer, H AU - Montag, K AU - Smolen, JS TI - A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis J2 - J Rheumatol PY - 2000 VL - 27 SP - 205 EP - 211 ER - TY - JOUR LB - 203. AU - Lozada, CJ TI - Glucosamine in osteoarthritis: questions remain J2 - Cleve Clin J Med PY - 2007 VL - 74 SP - 65 EP - 71 ER - TY - JOUR LB - 204. AU - Matheson, AJ AU - Perry, CM TI - Glucosamine: a review of its use in the management of osteoarthritis J2 - Drugs Aging PY - 2003 VL - 20 SP - 1041 EP - 1060 ER - TY - JOUR LB - 205. AU - McAlindon, TE TI - Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis J2 - JAMA PY - 2000 VL - 283 SP - 1469 EP - 1475 ER - TY - JOUR LB - 206. AU - McAlindon, T TI - Glucosamine and chondroitin for osteoarthritis? J2 - Bull Rheum Dis PY - 2001 VL - 50 SP - d-4 ER - TY - JOUR LB - 207. AU - McAlindon, TE TI - Nutritional factors and osteoarthritis: recent developments J2 - Curr Opin Rheumatol PY - 2005 VL - 17 SP - 647 EP - 652 ER - TY - JOUR LB - 208. AU - McAlindon, TE TI - Is treatment with chondroitin efficacious for osteoarthritis? J2 - Nat Clin Pract Rheumatol PY - 2007 VL - 3 SP - 606 EP - 607 ER - TY - JOUR LB - 209. AU - Reginster, JY AU - Bruyere, O AU - Neuprez, A TI - Current role of glucosamine in the treatment of osteoarthritis J2 - Rheumatology PY - 2007 VL - 46 SP - 731 EP - 735 ER - TY - JOUR LB - 210. AU - Towheed, TE AU - Anastassiades, T TI - Glucosamine therapy for osteoarthritis: an update J2 - J Rheumatol PY - 2007 VL - 34 SP - 1787 EP - 1790 ER - TY - JOUR LB - 211. AU - Vlad, SC AU - LaValley, MP AU - McAlindon, TE AU - Felson, DT TI - Glucosamine for pain in osteoarthritis: why do trial results differ? J2 - Arthritis Rheum PY - 2007 VL - 56 SP - 2267 EP - 2277 ER - TY - JOUR LB - 212. AU - Zerkak, D AU - Dougados, M TI - The use of glucosamine therapy in osteoarthritis J2 - Curr Pain Headache Rep PY - 2004 VL - 8 SP - 507 EP - 511 ER - TY - JOUR LB - 213. AU - Bruyere, O AU - Honore, A AU - Ethgen, O AU - Rovati, LC AU - Giacovelli, G AU - Henrotin, YE TI - Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate J2 - Osteoarthritis Cartilage PY - 2003 VL - 11 SP - 1 EP - 5 ER -